ROLE OF VITAMIN-D METABOLITES IN THE PREVENTION OF THE OSTEOPENIA INDUCED BY OVARIECTOMY IN THE AXIAL AND APPENDICULAR SKELETON OF THE RAT

被引:12
作者
ERBEN, RG
KOHN, B
WEISER, H
SINOWATZ, F
RAMBECK, WA
机构
[1] Institute of Physiology, Physiological Chemistry and Nutrition Physiology, Ludwig-Maximilians-University, Munich
[2] Research Department, Hoffmann-La Roche Ltd., Basel
[3] Institute of Veterinary Anatomy, Veterinary Faculty, Ludwig-Maximilians-University, Munich
来源
ZEITSCHRIFT FUR ERNAHRUNGSWISSENSCHAFT | 1990年 / 29卷 / 04期
关键词
OVARIECTOMY; QUANTITATIVE BONE HISTOMORPHOMETRY; BONE MINERALIZATION; OSTEOPENIA; VITAMIN-D;
D O I
10.1007/BF02023080
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Forty Fischer-344 rats (10 weeks old, 130 g BW) were either bilaterally ovariectomized (OVX) or sham-operated (SHAM). The rats were allocated to the following groups: SHAM; OVX; OVX + 15 ng 1-alpha,25-dihydroxyvitamin D3 [1,25(OH)2D3]/rat/d; OVX + 30 ng 1-alpha,24R,25-trihydroxyvitamin D3 [1,24,25(OH)3D3]/rat/d; OVX + 15 ng 1,25(OH)2D3/rat/d + 30 ng 1,24,25(OH)3D3/rat/d. The vitamin D metabolites were fed orally starting 4 weeks after surgery. Urine and blood samples were taken at several time points during the experiment. Twenty-one weeks after surgery all rats were sacrificed, and the proximal tibiae and the first lumbar vertebrae were processed undecalcified for static bone histomorphometry. Ovariectomy induced a 40 % reduction in vertebral cancellous bone area, and a 69 % reduction in tibial cancellous bone area. This bone loss in OVX rats was associated with moderately increased biochemical and histomorphometric indices of bone formation and resorption as compared to values in sham-operated animals. Through inhibition of bone resorption, treatment of OVX rats with 1,25(OH)2D3, 1,24,25(OH)3D3, and the metabolite combination prevented the ovariectomy-induced osteopenia in the lumbar vertebra, and partially prevented cancellous bone osteopenia in the tibial metaphysis. However, OVX rats receiving 1,25(OH)2D3 alone or in combination with 1,24,25(OH)3D3 exhibited hypercalcemia, hyperphosphatemia, hypercalciuria, and impaired bone mineralization. Treatment of OVX rats with 1,24,25(OH)3D3 alone, on the other hand, only slightly increased serum calcium levels and did not impair bone mineralization. Furthermore, the inclusion of 1,24,25(OH)3D3 with 1,25(OH)2D3 partially antagonized the untoward effects of 1,25(OH)2D3 on bone mineralization. These data suggest that the actions of 1,24,25(OH)3D3 on bone metabolism might differ from that of 1,25(OH)2D3, and that 1,25(OH)2D3 and, particularly, 1,24,25(OH)3D3 may be potentially effective agents for the prophylaxis of postmenopausal osteoporosis.
引用
收藏
页码:229 / 248
页数:20
相关论文
共 49 条
[1]  
Aloia J.F., Role of calcitriol in the treatment of postmenopausal osteoporosis, Metabolism, 39, pp. 35-38, (1990)
[2]  
Au W.Y.M., Inhibition by 1,25-dihydroxycholecalciferol of hormonal secretion of rat parathyroid gland in organ culture, Calcif Tissue Int, 36, pp. 384-391, (1984)
[3]  
Baron R., Vignery A., Neff L., Silverglate A., Santa Maria A., Processing of undecalcified bone specimens for bone histomorphometry, Bone histomorphometry: techniques and interpretation, pp. 13-35, (1983)
[4]  
Boskey A.L., Noncollagenous matrix proteins and their role in mineralization, Bone Min, 6, pp. 111-123, (1989)
[5]  
Caniggia A., Nuti R., Lore F., Martini G., Turchetti V., Righi G., Long-term treatment with calcitriol in postmenopausal osteoporosis, Metabolism, 39, pp. 43-49, (1990)
[6]  
Chesnut C.H., Drug therapy: calcitonin, bisphosphonates, anabolic steroids, and hPTH (1–34), Osteoporosis: etiology, diagnosis, and management, pp. 403-414, (1988)
[7]  
Christiansen C., Christensen, McNair P., Hagen C., Stocklund K-E, TransbOl I., Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females, Eur J Clin Invest, 10, pp. 273-279, (1980)
[8]  
Christiansen C., Christensen, ROdbro P., Hagen C., TransbOl I., Effect of 1,25-dihydroxyvitamin D<sub>3</sub> in itself or combined with hormone treatment in preventing postmenopausal osteoporosis, Eur J Clin Invest, 11, pp. 305-309, (1981)
[9]  
Erben R.G., Kohn B., Rambeck W.A., Zucker H., Histomorphometric analysis of the rat proximal tibial metaphysis by “linear scanning≓, Scanning Microsc, 4, pp. 625-640, (1990)
[10]  
Eriksen E.F., Colvard D.S., Berg N.J., Graham M.L., Mann K.G., Spelsberg T.C., Riggs B.L., Evidence of estrogen receptors in normal human osteoblast-like cells, Science, 241, pp. 84-86, (1988)